These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 173758

  • 1. Mechanism of immunologic resistance to herpes simplex virus 1 (HSV-1) infection.
    Rager-Zisman B, Allison AC.
    J Immunol; 1976 Jan; 116(1):35-40. PubMed ID: 173758
    [Abstract] [Full Text] [Related]

  • 2. HSV-1 infection and immunity in immunosuppressed mice.
    Litwińska B, Sadowski W, Kańtoch M.
    Acta Virol; 1987 Aug; 31(4):298-306. PubMed ID: 2892379
    [Abstract] [Full Text] [Related]

  • 3. Delayed hypersensitivity and immune protection against herpes simplex virus: suppressor T cells that regulate the induction of delayed hypersensitivity effector T cells also regulate the induction of protective T cells.
    Schrier RD, Ishioka GY, Pizer LI, Moorhead JW.
    J Immunol; 1985 May; 134(5):2889-93. PubMed ID: 2580006
    [Abstract] [Full Text] [Related]

  • 4. Protection of neonatal mice against herpes simplex virus infection: probable in vivo antibody-dependent cellular cytotoxicity.
    Kohl S, Loo LS.
    J Immunol; 1982 Jul; 129(1):370-6. PubMed ID: 6282968
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Contributions of antibody and T cell subsets to protection elicited by immunization with a replication-defective mutant of herpes simplex virus type 1.
    Morrison LA, Knipe DM.
    Virology; 1997 Dec 22; 239(2):315-26. PubMed ID: 9434723
    [Abstract] [Full Text] [Related]

  • 7. Autologous antibody is protective against HSV-1 infection of the immunocompromised mouse.
    Alexander TS, Rosenthal KS.
    J Lab Clin Med; 1990 Sep 22; 116(3):400-7. PubMed ID: 2169516
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The role of natural killer cells and interferon in resistance to acute infection of mice with herpes simplex virus type 1.
    Bukowski JF, Welsh RM.
    J Immunol; 1986 May 01; 136(9):3481-5. PubMed ID: 2420892
    [Abstract] [Full Text] [Related]

  • 10. The role of T cells in anti-herpes simplex virus immunity. I. Induction of antigen-specific cytotoxic T lymphocytes.
    Pfizenmaier K, Jung H, Starzinski-Powitz A, Röllinghoff M, Wagner H.
    J Immunol; 1977 Sep 01; 119(3):939-44. PubMed ID: 70478
    [Abstract] [Full Text] [Related]

  • 11. Immunogenicity of subviral herpes simplex virus preparations: protection of mice against intraperitoneal infection with live virus.
    Kutinová L, Vonka V, Slichtová V.
    Acta Virol; 1980 Dec 01; 24(6):391-8. PubMed ID: 6111199
    [Abstract] [Full Text] [Related]

  • 12. Lyt-1+ T cells participate in recovery from ocular herpes simplex virus type 1 infection.
    Oakes JE, Rector JT, Lausch RN.
    Invest Ophthalmol Vis Sci; 1984 Feb 01; 25(2):188-94. PubMed ID: 6321384
    [Abstract] [Full Text] [Related]

  • 13. Defective production of anti-herpes simplex virus antibody by neonatal mice. Reconstitution with Ia+ macrophages and T helper lymphocytes from nonimmune adult syngeneic mice.
    Kohl S, Thomas JW, Loo LS.
    J Immunol; 1986 Apr 15; 136(8):3038-44. PubMed ID: 3007609
    [Abstract] [Full Text] [Related]

  • 14. Acute morphine administration reduces white blood cells' capability to induce innate resistance against HSV-1 infection in BALB/c mice.
    Jamali A, Bamdad T, Soleimanjahi H, Pakdel FG, Arefian E.
    Neuroimmunomodulation; 2007 Apr 15; 14(1):16-23. PubMed ID: 17700036
    [Abstract] [Full Text] [Related]

  • 15. A detergent-soluble extract of virus-infected cells free from infectious virus protects mice from lethal herpes simplex virus infection.
    Ohashi Y, Sakaue Y, Kato S, Wada T, Sato K.
    Biken J; 1980 Dec 15; 23(4):199-204. PubMed ID: 6266395
    [Abstract] [Full Text] [Related]

  • 16. Neuroinvasive properties of herpes simplex virus type 1 glycoprotein variants are controlled by the immune response.
    Mitchell BM, Stevens JG.
    J Immunol; 1996 Jan 01; 156(1):246-55. PubMed ID: 8598469
    [Abstract] [Full Text] [Related]

  • 17. Augmentation of immunity to herpes simplex virus by in vivo administration of interleukin 2.
    Rouse BT, Miller LS, Turtinen L, Moore RN.
    J Immunol; 1985 Feb 01; 134(2):926-30. PubMed ID: 2981270
    [Abstract] [Full Text] [Related]

  • 18. Inhibitory effect of herpes simplex virus infection to target cells on recognition of minor histocompatibility antigens by cytotoxic T lymphocytes.
    Kuzushima K, Isobe K, Morishima T, Takatsuki A, Nakashima I.
    J Immunol; 1990 Jun 15; 144(12):4536-40. PubMed ID: 2161874
    [Abstract] [Full Text] [Related]

  • 19. Interleukin-12- and gamma interferon-dependent innate immunity are essential and sufficient for long-term survival of passively immunized mice infected with herpes simplex virus type 1.
    Vollstedt S, Franchini M, Alber G, Ackermann M, Suter M.
    J Virol; 2001 Oct 15; 75(20):9596-600. PubMed ID: 11559791
    [Abstract] [Full Text] [Related]

  • 20. Mechanism of recovery from systemic herpes simplex virus infection. I. Comparative effectiveness of antibody and reconstitution of immune spleen cells on immunosuppressed mice.
    Worthington M, Conliffe MA, Baron S.
    J Infect Dis; 1980 Aug 15; 142(2):163-74. PubMed ID: 6967924
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.